End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,890 KRW | -2.00% |
|
-5.15% | -49.36% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicine and Pharmaceutical Research and Development
100.0
%
| 3,583 | 100.0 % | 10,294 | 100.0 % | +187.32% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 3,583 | 100.0 % | 10,294 | 100.0 % | +187.32% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kwang-Rak Park
CEO | Chief Executive Officer | - | - |
Myung-Hwa Kim
CEO | Chief Executive Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Myung-Hwa Kim
CEO | Chief Executive Officer | - | - |
Kwang-Rak Park
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,873,968 | 9,133,363 ( 65.83 %) | 0 | 65.83 % |
Company contact information
![address curacle co.,ltd.(A365270)](https://cdn.zonebourse.com/static/address/125137973.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-49.36% | 60.33M | |
+21.39% | 127B | |
+24.45% | 117B | |
+25.44% | 27.67B | |
-18.94% | 20.33B | |
-15.17% | 16.79B | |
-16.13% | 15.63B | |
+12.65% | 14.84B | |
-47.10% | 14.65B | |
+57.87% | 14.43B |
- Stock Market
- Equities
- A365270 Stock
- Company curacle co.,ltd.